Gareth Jones was supposed to take up his new role at the end of November, but having already completed the handover at his old company, he starts today (Monday)
The new chief financial officer of () has joined regenerative medical devices company a month earlier than expected.
Gareth Jones’ appointment was first unveiled back in July and he was originally scheduled to take up his new role at the end of November.
But he has already completed the handover process in his previous position as the chief number cruncher at PLC ().
“I am delighted to welcome Gareth to the group,” said chief executive Steve Couldwell.
“He will play a pivotal role in the strategic direction, focus and acceleration of our commercial success.
He added: “Utilising his experience and knowledge of both operational and financial enhancement initiatives, alongside his international and listed company experience, we expect Gareth to help execute on our vision and accelerate sustainable long-term shareholder value.”
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE